Literature DB >> 566556

Interaction of vitamin K dependent proteins with membranes.

G L Nelsestuen, W Kisiel, R G Di Scipio.   

Abstract

The membrane-binding characteristics of six vitamin K dependent plasma proteins, which have homologous amino acid sequences, were compared. All of these proteins display calcium-dependent membrane binding and the identified equilibria for protein-membrane binding are qualitatively the same for all proteins. Quantitative characteristics of these protein-membrane interactions allow organization into distinct subgroups. Protein C and factor VII form a subgroup which has extemely low affinity for bilayer membranes; prothrombin, factor X, and protein S form the tightest complexes with membranes and factor IX displays intermediate affinity. In the presence of manganese (which substitutes for calcium in a cation-dependent protein transition), calcium titration of protein-membrane binding shows the same calcium dependence for all proteins except prothrombin which requires lower calcium. These protein-membrane binding characteristics agree very well with the relatedness of these proteins based on their partial amino-terminal sequences.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566556     DOI: 10.1021/bi00604a017

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  35 in total

1.  Cardiolipin is a normal component of human plasma lipoproteins.

Authors:  H Deguchi; J A Fernandez; T M Hackeng; C L Banka; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms.

Authors:  Shiva Keshava; Usha R Pendurthi; Charles T Esmon; L Vijaya Mohan Rao
Journal:  J Thromb Haemost       Date:  2020-06-25       Impact factor: 5.824

Review 3.  The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

Authors:  M Hessing
Journal:  Biochem J       Date:  1991-08-01       Impact factor: 3.857

4.  Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain.

Authors:  A Hillarp; B Dahlbäck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  Manipulation of the membrane binding site of vitamin K-dependent proteins: enhanced biological function of human factor VII.

Authors:  A M Shah; W Kisiel; D C Foster; G L Nelsestuen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 6.  Peripheral membrane associations of matrix metalloproteinases.

Authors:  Steven R Van Doren; Tara C Marcink; Rama K Koppisetti; Alexander Jurkevich; Yan G Fulcher
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2017-04-23       Impact factor: 4.739

7.  Multiplexed silicon photonic sensor arrays enable facile characterization of coagulation protein binding to nanodiscs with variable lipid content.

Authors:  Ellen M Muehl; Joshua M Gajsiewicz; Sara M Medfisch; Zachary S B Wiersma; James H Morrissey; Ryan C Bailey
Journal:  J Biol Chem       Date:  2017-08-11       Impact factor: 5.157

8.  Conformational changes in activated protein C caused by binding of the first epidermal growth factor-like module of protein S.

Authors:  T M Hackeng; S Yegneswaran; A E Johnson; J H Griffin
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

9.  Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding.

Authors:  Joel R Livingston; Michael R Sutherland; Harvey M Friedman; Edward L G Pryzdial
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

10.  An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.

Authors:  Xia Yang; Peter N Walsh
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.